Ultragenyx Vaults Toward Commercialization as FDA Accepts Landmark Gene Therapy BLA
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has accepted a biologics license application for a gene therapy from Ultragenyx. This move is seen as a step toward commercialization for the company. The acceptance is considered a landmark development for the gene therapy.